Back to Directory
Genflow Biosciences
Greater London
Founded 2020
Gene therapies targeting the ageing process and age-related disease
Genflow Biosciences is a longevity-focused biotechnology company developing gene therapies designed to slow or halt the biological ageing process and delay age-related disease.
Its lead compound uses an adeno-associated viral vector to deliver a centenarian variant of the SIRT6 gene, with a pipeline spanning human and veterinary applications.
Current research priorities include Metabolic Dysfunction-Associated Steatohepatitis, a prevalent liver disease with no effective treatment, and Werner Syndrome, a rare premature-ageing genetic disorder.